| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |